NASDAQ · Biotechnology

CSBR (CSBR) Stock

$5.19 +0.00% NASDAQ: CSBR Healthcare

Valuation

MetricValue
Price$5.19
Market Cap$72.11M
P/E Ratio18.33
P/B Ratio21.00
P/S Ratio1.45
EPS (TTM)$0.33
52-Week High$9.63
52-Week Low$5.19
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE125.00%
ROA15.63%
ROCE166.67%
Gross Margin8.77%
Operating Margin8.77%
Net Margin-3.88%
Debt/Equity1.17
Current Ratio0.92

Annual Financials (USD)

Metric20212022202320242025
Revenue$41.0M$49.0M$54.0M$50.0M$57.0M
Operating Profit$0$1.0M$-4.0M$-7.0M$5.0M
Net Profit$0$1.0M$-5.0M$-7.0M$5.0M
EPS$0.02$0.04$-0.39$-0.54$0.33
Op Margin0.9%1.2%-8.3%-13.8%8.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$28.0M$35.0M$34.0M$26.0M$32.0M
Total Liabilities$20.0M$26.0M$30.0M$28.0M$29.0M
Cash$5.0M$9.0M$10.0M$3.0M$10.0M
Borrowings$10.0M$9.0M$9.0M$7.0M$6.0M

Latest News

Zacks Initiates Coverage of Champions Oncology With Neutral Recommendation Zacks · Jul 22, 2026 Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026 ACCESS Newswire · Jul 20, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$6.0M$4.0M$-6.0M$7.0M
Investing Cash Flow$-6.0M$-5.0M$-6.0M$-2.0M$-1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-4.0M$4.0M$1.0M$-7.0M$7.0M
Free Cash Flow$-5.0M$4.0M$1.0M$-7.0M$7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA11.43
FCF Yield4.54%
Quick Ratio0.98
Interest Coverage—
Return 1Y-26.37%
Return 3Y-13.11%
Return 5Y-36.95%

Ownership

Insiders Held26.67%
Institutions Held41.37%
Institutions Float Held56.41%
Institutional HolderSharesReport Date
Battery Management Corp.2,421,6732026-03-31
NEA Management Company, LLC1,713,7202026-03-31
Tocqueville Asset Management L.p.319,6742026-03-31
Vanguard Capital Management LLC299,5202026-03-31
Morgan Stanley242,3002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARTV $11.27 -2.68% -2.29 $278.56M 0.00%
ATRAAtara Biotherapeutics, Inc. $7.71 -2.41% -11.97 $69.47M 0.00%
CNTB $2.07 -1.67% -2.31 $130.02M 0.00%
IFRX $1.84 +6.98% -4.16 $132.91M 0.00%
IMA $5.69 +1.07% -1.49 $64.18M 0.00%

About CSBR

CSBR is led by CEO Robert Brainin, employs 210 people, headquartered in US, publicly traded since 2007.

CSBR stock trades at $5.19 with a market capitalization of $72.11M. The stock is valued at a price-to-earnings (P/E) ratio of 18.33, price-to-book of 21.00, price-to-sales of 1.45. Over the past 52 weeks the stock has ranged between $5.19 and $9.63, and currently trades 46.1% below its 52-week high.

On profitability, CSBR generates a return on equity (ROE) of 125.00% — well above the market average, a sign of a high-quality business, return on capital employed of 166.67%, an operating margin of 8.77%, a net profit margin of -3.88%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides